Clinical Trial Update: A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Spain is evaluating first-line durvalumab with platinum-based chemotherapy followed by durvalumab plus olaparib for advanced or recu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Olaparib (Olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced or Recurrent Endometrial Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING